CRON

Cronos Group Inc

3.20 -0.20 (-5.88%)

Forsinkede priser fra NASDAQ, i USD Markedet stengt

Handle

S

3.19

K

3.22

Topp

Italia

seekingalpha.com/news/3874037-tilray-gets-approval-in-poland-to-commercialize-medical-cannabis-products?source=content_type%3Areact%7Cfirst_level_url%3Amarket-news%7Csection_asset%3Amain 🍀🍀🍀 $TLRY (Tilray Brands Inc) $ACB (Aurora Cannabis Inc) $CRON (Cronos Group Inc) $CGC (Canopy Growth Corp) $ZYNE... Vis flere

Tilray gets approval in Poland to commercialize medical cannabis products

seekingalpha.com

Tilray Brands (TLRY) said its unit Tilray Medical received approval to commercialize its medical cannabis products in Poland

Polen

$HEXO (HEXO Corp) oh my!! This thing looks yummmm! Too bad they removed leverage for it. This one is still so good if you prefer trading with no leverage. $TLRY (Tilray Brands Inc) $CRON (Cronos Group Inc) $ACB (Aurora Cannabis Inc)

Sverige

$TLRY (Tilray Brands Inc) | $AMRS (Amyris Inc) | $CGC (Canopy Growth Corp) | $ACB (Aurora Cannabis Inc) | $CRON (Cronos Group Inc) 𝘾𝙖𝙣𝙣𝙖𝙗𝙞𝙨 𝙞𝙣 𝙐𝙎 𝙞𝙨 𝙖 $100 𝙗𝙞𝙡𝙡𝙞𝙤𝙣 𝙤𝙥𝙥𝙤𝙧𝙩𝙪𝙣𝙞𝙩𝙮❓❓❓ www.foxbusiness.com/markets/cannabis-us-100-billion-opportunity-tilray-ceo-irwin-simon-says *This... Vis flere

Cannabis in US is a ‘$100 billion opportunity,’ Tilray CEO Irwin Simon says

www.foxbusiness.com

The legalization of marijuana at the federal level will be a $100 billion opportunity extending beyond just recreational and medical use, says Tilray CEO Irwin Simon.

Storbritannia

Redigert

$CRON (Cronos Group Inc) Q3 2022-resultatrapport forventes publisert

2

NOV

RAPPORTER

Cronos Group Inc Q3 2022 det forventes at inntektsrapporten publiseres før markedet åpner

CRON

Cronos Group Inc

3.20

-0.20

(-5.88%)

Handle

Cronos Group Inc

3.19

-0.20 (-5.88%)

Handle

Storbritannia

Redigert

$CRON (Cronos Group Inc) Q3 2022 earnings report is expected to be released

Cronos Group Inc

3.19

-0.20 (-5.88%)

Handle